Concepedia

Seok-Hyun Kim

SK

Statistics

Publications

8

Citations

517

H-Index

8

Active since

2004

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Sungkyunkwan University

University of Pennsylvania

Samsung (South Korea)

Molecular Oncology (United States)

Seok-Hyun Kim is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and chemotherapy.

ORCID

Publications per year

2004–2017

8

Publications

8

Reduction of TRAIL-Induced Mcl-1 and cIAP2 by c-Myc or Sorafenib Sensitizes Resistant Human Cancer Cells to TRAIL-Induced Death

M. Ricci, Seok-Hyun Kim, Kazuhiro Ogi et al. · Cancer Cell · 2007 · 256 citations · Full text

, , +14

Cell Cycle–Dependent and Schedule-Dependent Antitumor Effects of Sorafenib Combined with Radiation

John P. Plastaras, Seok-Hyun Kim, Yingqiu Y. Liu et al. · Cancer Research · 2007 · 141 citations

, , +17

Prognostic significance of the lymphocyte-to-monocyte ratio in patients with small cell lung cancer

Se‐Il Go, Rock Bum Kim, Haa‐Na Song et al. · Medical Oncology · 2014 · 44 citations

, , +10

IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms

Munenori Takaoka, Seok-Hyun Kim, Takaomi Okawa et al. · Cancer Biology & Therapy · 2007 · 27 citations · Full text

, , +15

The Clinical Impact of the Sum of the Maximum Standardized Uptake Value on the Pretreatment with <sup>18</sup>F-FDG-PET/CT in Small-Cell Lung Cancer

Se‐Il Go, Haa‐Na Song, Jung-Hun Kang et al. · Oncology · 2013 · 13 citations

, , +16

1–5 of 8